English
|
Spanish
Supporting oncology professionals through education
Login
Register
The content on this site is intended for healthcare professionals only
Menu
Home
News
Journal
Video
e
learning
Events
Conferences
About us
Keyword
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas
News
Latest news
Sign up for news alerts
Submit your news
Explore
Bone
Brain & nervous system
Breast
Colorectal & gastro
Haematology oncology
Head & neck
Hepatobiliary pancreatic
Lung & pleura
Melanoma & skin
Neuroendocrine
Ovary & gynaecology
Paediatric
Prostate & urology
Sarcomas
Journal information
Journal home
Charges
Editorial board
Founding editors
Editor-in-chief
Contact us
Author information
Submit article
Author guidelines
Editorial policies
Copyright information
Why publish with us
Reviewer information
Reviewer guidelines
Memberships
Videos
Recent videos
Sign up
Explore
Bone
Brain & nervous system
Breast
Colorectal & gastro
Haematology oncology
Head & neck
Hepatobiliary pancreatic
Lung & pleura
Melanoma & skin
Neuroendocrine
Ovary & gynaecology
Paediatric
Prostate & urology
Sarcomas
Conferences
Latest conferences
Sign up for latest coverage
Submit your event
About
e
cancer
About
e
cancer
Our founders
Funding statement
Contact us
Home
News
Journal
Video
e
learning
Events
Conferences
About us
Keyword
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
+
-
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas
Breast cancer during pregnancy
Share :
EBCC 7
17 Nov 2011
Please rate this video
The information in this video was of interest to me
The information in this video is likely to improve my clinical practice or research
I would recommend this video to my colleagues
Published:
22 Apr 2010
Views:
10428
Rating:
Save
Rate video
Dr. Sibylle Loibl - University of Frankfurt and German Breast Group
Dr Loibl talks about research indicating that using cytotoxic agents to treat pregnant women with breast cancer does not pose a threat to their unborn child.
See more from Dr Sibylle Loibl, speaking at EBCC 6 in 2008:
Click here for Dr Loibl's EBCC 6 press briefing
Click here for an interview with Dr Loibl from EBCC 6
Categories:
Breast
Cytotoxics
Related Videos
ESMO 2024: Highlights and analysis
Assoc Prof Bishal Gyawali - Queen's University, Kingston, Canada
16 Sep 2024
Trastuzumab deruxtecan effective against brain metastases in HER2-positive...
Dr Nancy Lin - Dana-Farber Cancer Institute, Boston, USA
14 Sep 2024
Endocrine therapy plus trastuzumab and pertuzumab shows excellent survival...
Dr Oleg Gluz - Evangeliches Krankenhaus Bethesda Klinik, Mönchengladbach...
14 Sep 2024
Hormonal receptor positive breast cancer adjuvant and metastatic indications
Dr Aurelio Castrellon - Memorial Cancer Institute, Miami, USA
12 Jul 2024
Trastuzumab deruxtecan significantly improves PFS In breast cancer patients...
Prof Giuseppe Curigliano - European Institute of Oncology, Milan, Italy
13 Jun 2024
Adjuvant avelumab versus control does not significantly improve DFS but does...
Prof Pier Conte - University of Padova, Padova, Italy
3 Jun 2024
HER2DX assay and survival outcomes: An individual-patient level meta-analysis...
Dr Guillermo Villacampa - Vall d'Hebron Institute of Oncology (VHIO)...
21 May 2024
Low-dose olanzapine after highly emetogenic chemotherapy can be the new...
Dr Jyoti Bajpai - Tata Memorial Centre, Mumbai, India
7 Dec 2023
Breast Cancer
Dr Nita Nair - Apollo Cancer Centres, Mumbai
6 Nov 2023
More from
e
cancer